BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11953351)

  • 1. H(2) receptor antagonists and prokinetics in dyspepsia: a critical review.
    Bytzer P
    Gut; 2002 May; 50 Suppl 4(Suppl 4):iv58-62. PubMed ID: 11953351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies.
    Allescher HD; Böckenhoff A; Knapp G; Wienbeck M; Hartung J
    Scand J Gastroenterol; 2001 Sep; 36(9):934-41. PubMed ID: 11521983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of cisapride and nizatidine in dyspepsia.
    Adelman A; Alper BS
    J Fam Pract; 1998 Jun; 46(6):457-8. PubMed ID: 9638107
    [No Abstract]   [Full Text] [Related]  

  • 4. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Forman D; Harris A; Innes M; Delaney B
    Aliment Pharmacol Ther; 2003 May; 17(10):1215-27. PubMed ID: 12755835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
    Ang TL; Fock KM; Teo EK; Chan YH; Ng TM; Chua TS; Tan JY
    J Gastroenterol; 2006 Jul; 41(7):647-53. PubMed ID: 16933001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional dyspepsia. Current treatment recommendations.
    Holtmann G; Talley NJ
    Drugs; 1993 Jun; 45(6):918-930. PubMed ID: 7691499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion.
    Eberl T; Barnert J; Dumitrascu DL; Fischer J; Wienbeck M
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):991-5. PubMed ID: 9895043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
    Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
    World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options in nonulcer dyspepsia.
    Talley NJ
    J Clin Gastroenterol; 2001 Apr; 32(4):286-93. PubMed ID: 11276271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
    Cochrane Database Syst Rev; 2003; (1):CD001960. PubMed ID: 12535421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyspepsia in primary care: acid suppression as effective as prokinetic therapy. A randomized clinical trial.
    Quartero AO; Numans ME; de Melker RA; Hoes AW; de Wit NJ
    Scand J Gastroenterol; 2001 Sep; 36(9):942-7. PubMed ID: 11521984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001960. PubMed ID: 15495023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials.
    Pittayanon R; Yuan Y; Bollegala NP; Khanna R; Lacy BE; Andrews CN; Leontiadis GI; Moayyedi P
    Am J Gastroenterol; 2019 Feb; 114(2):233-243. PubMed ID: 30337705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.
    Redstone HA; Barrowman N; Veldhuyzen Van Zanten SJ
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1291-9. PubMed ID: 11552898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.
    Holtmann G; Gschossmann J; Mayr P; Talley NJ
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1641-8. PubMed ID: 12197843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
    Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
    Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
    Madisch A; Heydenreich CJ; Wieland V; Hufnagel R; Hotz J
    Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia.
    Holtmann G; Gschossmann J; Karaus M; Fischer T; Becker B; Mayr P; Gerken G
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1459-65. PubMed ID: 10571602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.